Seres Therapeutics (MCRB) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Seres Therapeutics (MCRB) over the last 8 years, with Q3 2025 value amounting to $53000.0.

  • Seres Therapeutics' Receivables - Other changed N/A to $53000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $53000.0, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is 6906.85% down from last year.
  • According to the latest figures from Q3 2025, Seres Therapeutics' Receivables - Other is $53000.0.
  • In the past 5 years, Seres Therapeutics' Receivables - Other registered a high of $125.0 million during Q1 2023, and its lowest value of $53000.0 during Q3 2025.
  • Its 3-year average for Receivables - Other is $18.9 million, with a median of $7.5 million in 2023.
  • Per our database at Business Quant, Seres Therapeutics' Receivables - Other soared by 14607.75% in 2024 and then plummeted by 9850.01% in 2025.
  • Over the past 3 years, Seres Therapeutics' Receivables - Other (Quarter) stood at $8.7 million in 2023, then crashed by 69.07% to $2.7 million in 2024, then tumbled by 98.02% to $53000.0 in 2025.
  • Its Receivables - Other was $53000.0 in Q3 2025, compared to $279000.0 in Q2 2025 and $1.6 million in Q1 2025.